# Prostate Cancer Active Surveillance Metformin Trial

> **NCT01733836** · PHASE2 · WITHDRAWN · sponsor: **University Health Network, Toronto**

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Metformin
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT01733836
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-01
- **Primary completion:** 2014-10
- **Final completion:** 2014-10
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The reason for this decision is that this study is being merged with a larger multi-centre study using the same agent in the same population.
- **Last updated:** 2013-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01733836

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01733836, "Prostate Cancer Active Surveillance Metformin Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01733836. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*